Imbalance of the autonomic nervous system at night in women with gestational diabetes

Diabetic Medicine

Volumn 27, Issue 9, 2010, Pages 988-994

  Poyhonen Alho M ^a   Viitasalo, M ^a   Nicholls, M G ^b   Lindstrom B M ^c   Vaananen H ^d   Kaaja, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Pharma   (Finland)

^d AALTO UNIVERSITY   (Finland)

Author keywords

autonomic nervous system; gestational diabetes; Heart Rate Variability (HRV); plasma adrenomedullin; plasma noradrenaline

Indexed keywords

ADRENOMEDULLIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; NIGHT; NORADRENALIN BLOOD LEVEL; PREGNANCY DIABETES MELLITUS;

ADRENOMEDULLIN; ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CATECHOLAMINES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIABETIC ANGIOPATHIES; FEMALE; HEART RATE; HUMANS; PREGNANCY;

EID: 77955902019     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03062.x     Document Type: Article

References (24)

1. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002 25 : 1862 1868.
2. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008 31 : 1668 1669.
3. Kaaja RJ, Poyhonen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006 24 : 131 141.
4. Mueller PJ. Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol 2007 34 : 377 384.
5. McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities, B.26. Eur Respir J 2007 29 : 156 178.
6. Tentolouris N, Liatis S, Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2006 1083 : 129 152.
7. Tentolouris N, Argyrakopoulou G, Katsilambros N. Perturbed autonomic nervous system function in metabolic syndrome. Neuromolecular Med 2008 10 : 169 178.
8. Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ et al. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study. Diabetes Care 2000 23 : 1369 1374.
9. Gasic S, Winzer C, Bayerle-Eder M, Roden A, Pacini G, Kautzky-Willer A. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus. Eur J Clin Invest 2007 37 : 42 47.
10. Taylor MM, Samson WK. Adrenomedullin and central cardiovascular regulation. Peptides 2001 22 : 1803 1807.
11. Lim SCB, Morgenthaler NGP, Subramaniam TB, Wu YSD, Goh SKB, Sum CFB. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with Type 2 diabetes. Diabetes Care 2007 30 : 1513 1519.
12. Di Iorio R, Marinoni E, Letizia C, Alo P, Villaccio B, Cosmi EV. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension 1998 32 : 758 763.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart Rate Variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996 93 : 1043 1065.
14. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998 98 : 547 555.
15. Mefford IN, Ward MM, Miles L, Taylor B, Chesney MA, Keegan DL et al. Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection. Life Sci 1981 28 : 477 483.
16. Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998 44 : 571 577.
17. Lechin F, Pardey-Maldonado B, van der Dijs B, Benaim M, Baez S, Orozco B et al. Circulating neurotransmitters during the different wake-sleep stages in normal subjects. Psychoneuroendocrinology 2004 29 : 669 685.
18. Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy 1999 18 : 173 187.
19. Weissman A, Lowenstein L, Peleg A, Thaler I, Zimmer EZ. Power spectral analysis of heart rate variability during the 100-g oral glucose tolerance test in pregnant women. Diabetes Care 2006 29 : 571 574.
20. Tulppo MP, Huikuri HV, Tutungi E, Kimmerly DS, Gelb AW, Hughson RL et al. Feedback effects of circulating norepinephrine on sympathetic outflow in healthy subjects. Am J Physiol Heart Circ Physiol 2005 288 : H710 715.
21. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y. Immunohistological localization and possible functions of adrenomedullin. Hypertens Res 2003 26 : S33 40.
22. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab 2000 85 : 1016 1020.
23. Saita M, Shimokawa A, Kunitake T, Kato K, Hanamori T, Kitamura K et al. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am J Physiol 1998 274 : R979 984.
24. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999 17 : 719 734.